Clinical Trials Logo
  1. Home
  2. Cardiovascular Diseases
  3. NCT05602103
  4. Details
NCT05602103 Clinical Trial

Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies

Cardiovascular Diseases Clinical Trial

Official title:
Identification of Anticancer Drugs Associated With Cancer Therapy-related Cardiac Dysfunction Reporting in Pediatrics - Analysis of the WHO Pharmacovigilance Database

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT05602103
Other study ID # Pharmaco_112022
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date November 5, 2024
Est. completion date January 6, 2025

Study information
Verified date April 2024
Source University Hospital, Caen
Contact Joachim Alexandre, MD, PhD
Phone +330231064770
Email alexandre-j@chu-caen.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Little is known about cancer therapy-related cardiac dysfunction occuring in children treated by anticancer drugs for malignancies. Here the investigators use VigiBase (http://www.vigiaccess.org/), the World Health Organization (WHO) database of individual safety case reports, to identify and describe cases of cancer therapy-related cardiac dysfunction associated with anticancer drugs.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 10000
Est. completion date January 6, 2025
Est. primary completion date January 1, 2025
Accepts healthy volunteers No
Gender All
Age group 0 Years to 18 Years
Eligibility Inclusion Criteria: - cases reported in the World Health Organization (WHO) database of individual safety case reports (vigibase) - related to children - and reported, or not, cancer therapy-related cardiac dysfunction Exclusion Criteria: - cases reported in the World Health Organization (WHO) database of individual safety case reports (vigibase) related to adult patients

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• use of anticancer drugs in monotherapy or in combination therapy
Cases of cancer therapy-related cardiac dysfunction associated with anticancer drugs will be identify and describe

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
University Hospital, Caen

Outcome
Type Measure Description Time frame Safety issue
Primary cancer therapy-related cardiac dysfunction associated with anticancer drugs identification and description of cases of cancer therapy-related cardiac dysfunction associated with anticancer drugs in the World Health Organization (WHO) database of individual safety case reports (vigibase) from inception to the April 31, 2024
Secondary Association between cancer therapy-related cardiac dysfunction and anticancer drug exposure in the World Health Organization (WHO) database of individual safety case reports (vigibase) Disproportionnality analyses in Vigibase (IC025 and/or ROR) perfomed on cases reported in the World Health Organization (WHO) database of individual safety case reports (vigibase) from inception to the April 31, 2024
Secondary Description of the malignancies for which the incriminated drugs have been prescribed Cases reported in the World Health Organization (WHO) database of individual safety case reports (vigibase) from inception to the April 31, 2024
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)